Biotechnology

Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers

by

U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November 20, 2020. Carlos Barria | Reuters Pharmaceutical companies appear to be hopeful about their growth under a Trump administration, after former President Joe Biden took a hardline stance on … Read more

Eli Lilly Beats on Earnings even as Weight Loss, Diabetes Drug Sales Fall Short

by

Eli lilly on thuresday reported Mixed Results For the fourth Quarter, even as demand for its blockbuster weight loss and diabetes treatment mounjaro sorad. The company’s Quarterly Earnings Topped Wall Street Estimates, but sales fell just short as mounjaro saw lower realized pructions. Zepbound and mounjaro have no underperformed expectations for two straight qualiers, with … Read more